[Temporal trends and clinical-epidemiological profile of visceral leishmaniasis-HIV coinfection in Brazilian states between 2009 and 2024]. [PDF]
França M +3 more
europepmc +1 more source
Epidemiologic aspects and spatial distribution of human visceral leishmaniasis: a cross-sectional study, Crateús, 2007-2023. [PDF]
Pinto ABD +5 more
europepmc +1 more source
Impact of COVID-19 on the incidence of visceral leishmaniasis in children and adolescents in the Northeast region, 2007-2022: time series study. [PDF]
Santos PHFD, Santos BRRD, Farias KF.
europepmc +1 more source
Factors associated with deaths due to visceral leishmaniasis among children at a hospital in the southwest of Maranhão state: a cross-sectional study, Imperatriz, 2010-2021. [PDF]
Teixeira MMP +7 more
europepmc +1 more source
Visceral Leishmaniasis in Gizan
E.A. Ibrahim +3 more
openaire +2 more sources
Response to "Diagnostic Caveats and Clinical Pitfalls in the Overlap of Leprosy and Para-Kala-Azar Dermal Leishmaniasis". [PDF]
Kwan RLY, Chia HY, Vasoo S, Pan JY.
europepmc +1 more source
Predicting Antileishmanial Activity of Plant-Derived Compounds Using Random Forest Modeling. [PDF]
Highgate A +3 more
europepmc +1 more source
mNGS-Assisted Diagnosis of Visceral Leishmaniasis Presenting as Hemophagocytic Lymphohistiocytosis: Two Cases Confirmed by rK39. [PDF]
Chang C +4 more
europepmc +1 more source
Temporal trends and spatial distribution of leishmaniasis based on biomes in Brazil, 2007 to 2020. [PDF]
Ferreira GB, Melchior LAK, Brilhante AF.
europepmc +1 more source
Sustaining the Elimination of Visceral Leishmaniasis: A Secondary Data Analysis of the National Kala-Azar Elimination Programme in Malda District, West Bengal, India (2018-2022). [PDF]
Halder T, Debnath P, Pal J, Ghosh M.
europepmc +1 more source

